- Diagnostic Différentiel
Drug Information for PHYSICIAN LABELING Quasense (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.15 mg/0.03 mg (91-Day Regimen) Rx only (Watson Pharma, Inc.): OVERDOSAGE
- INDICATIONS AND USAGE
- ADVERSE REACTIONS
- DOSAGE AND ADMINISTRATION
- HOW SUPPLIED
- Liens externes liés à PHYSICIAN LABELING Quasense (Levonorgestrel and Ethinyl Estradiol Tablets USP) 0.15 mg/0.03 mg (91-Day Regimen) Rx only (Watson Pharma, Inc.)
Serious ill effects have not been reported following acute ingestion of large doses of oral contraceptives by young children. Overdosage may cause nausea, and withdrawal bleeding may occur in females.
NONCONTRACEPTIVE HEALTH BENEFITS
The following noncontraceptive health benefits related to the use of oral contraceptives are supported by epidemiological studies which largely utilized oral contraceptive formulations containing doses exceeding 0.035 mg of ethinyl estradiol or 0.05 mg of mestranol.
Effects on menses:
May decrease blood loss and may decrease incidence of iron-deficiency anemia
May decrease incidence of dysmenorrhea
Effects related to inhibition of ovulation:
May decrease incidence of functional ovarian cysts
May decrease incidence of ectopic pregnancies
Effects from long-term use:
May decrease incidence of fibroadenomas and fibrocystic disease of the breast
May decrease incidence of acute pelvic inflammatory disease
May decrease incidence of endometrial cancer
May decrease incidence of ovarian cancer
- Drug Information Provided by National Library of Medicine (NLM).